West Pharmaceutical Servs: Q1 Earnings Insights

West Pharmaceutical Servs WST reported its Q1 earnings results on Thursday, April 28, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

West Pharmaceutical Servs beat estimated earnings by 8.49%, reporting an EPS of $2.3 versus an estimate of $2.12.

Revenue was up $49.30 million from the same period last year.

Last quarter the company beat on EPS by $0.13 which was followed by a 4.6% drop in the share price the next day.

Here's a look at West Pharmaceutical Servs's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	1.91	1.80	1.74	1.43
EPS Actual	2.04	2.06	2.46	2.05
Revenue Estimate	710.20M	687.09M	669.38M	611.39M
Revenue Actual	730.80M	706.50M	723.60M	670.70M

To track all earnings releases for West Pharmaceutical Servs visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar